PPAR-γ, which is involved in insulin sensitivity of NAFLD [12], and apoptosis in other models [33, 34], could be upregulated and activated by GRb1 [24, 35]. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.